Noveris Health Sciences is trading at CA$0.05, down 9.09%, amid broader market and biotech-sector weakness; available evidence does not establish a direct catalyst for the move.
- The provided live price shows a further decline from the October 22 close of CA$0.06, when the stock fell 15.38%.
- No company-specific announcement dated October 23 was found; the company’s latest release is its September 9 annual and special meeting results.